Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Discover which cashback cards are fee-free and how they can benefit your finances. Make informed choices!
26,519 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Wells Fargo lowers Meta's price target to 765 but preserves a bullish view as Meta reports strong Q1 FY2026 results a...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Radian Group names Mike Weinbach CEO-elect as Rick Thornberry set to retire by year-end 2026. The move coincides with...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Oil prices stayed contained as Beijing taps strategic stockpiles, a trend analysts say explains why crude hasn’t surg...
As markets digest AI hype, Synopsys faces a potential growth trap: strong licensing revenue amid squeezed margins and...
A growing share of managers treat AI as teammates and even show them on org charts, but new research links this to ac...
AI-driven analysis explores XRP's possible path to higher prices if Ripple secures a Fed master account. The piece ou...
Burlington Stores keeps evolving in a crowded value retail market. After Q1 2026, investors should focus on margins, ...
Jeff Immelt debuts a Substack column to speak openly about GE’s legacy and his life after the helm. The move mirrors ...
New grads confront a tight job market as AI reshapes hiring. A veteran who weathered the 2008 crash offers a practica...